Best Sustainability Tech Companies in Baden Wurttemberg, Germany
The 99 best Sustainability Tech companies in Baden Wurttemberg, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: CureVac.
Our analysis of 50 Sustainability Tech companies
$6.1b in tracked funding; 91% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
Ranked: Best Sustainability Tech companies in Baden Wurttemberg
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2Degrees Offers smart metering and wind & solar analysis software solutions | — | — | — | 2015 | Stefan Querfurth Founder | — | — | — |
| 2 | achtBytes Energy management solutions for commercial buildings | — | — | — | 2019 | Gareth Lambe Managing Director | HubSpot CMS HubUIKitHubSpot+10 | — | — |
| 3 | alphaEOS Intelligent heating control system | — | — | — | 2013 | Jonathan Busse CEO | — | 8 patents Building automation systems for HVAC control and climate monitoring | — |
| 4 | Altenburger Technologies Smart building automation solution provider | — | — | — | 1936 | Detlef Siegfried Managing Director | — | — | — |
| 5 | AmetiXGreen Provider of solutions for measuring and quantifying sustainability for sports sector | — | — | — | 2020 | Viktoria Unger Co-Founder | — | — | — |
| 6 | Ammonigy Developer of decentralized ammonia-cracking systems for CO2-free combustion engine and process heat | — | — | — | 2020 | Gerhard Wannemacher Co-Founder & Technical Director | — | 6 patents Patents concentrated in chemistry & materials | — |
| 7 | AMPERYN Provider of Web3.0 platform for micro grid management and energy balancing | — | — | — | 2024 | Niko Unger Co-Founder & CFO | — | — | — |
| 8 | Ape Labs App-based platform offering smart LED lights | — | — | — | 2009 | Julius Schrenk Founder & CEO | WordPressMySQLPHP+20 | — | — |
Top 12 Sustainability Tech companies in Baden Wurttemberg
#1
Series A · Freiburg im Breisgau, Baden Wurttemberg · founded 2020 · 11 employees$8.7Mraised▾
Provider of solutions for a recyclability assessment tool. It helps companies along the packaging value chain assess recyclability with software and data. It consolidates research on country-specific recyclability and embeds it in web application.
- Oct 2024Series A$6.8M
- Mar 2023Seed$1.9M
- Aug 2021Seed—
#2
Series A · Offenburg, Baden Wurttemberg · founded 2023$3.7Mraised▾
Manufacturer of electric heaters for zero-emission renewable industrial heat. The business designs electric heating solutions reaching high temperatures. It provides an alternative to fossil fuel combustion for industrial processes. The technology is intended for retrofitting industrial processes, enabling carbon dioxide reductions across industries.
- Nov 2024Series A$3.7M
- Apr 2024Seed—
#3
Series C · Ludwigsburg, Baden Wurttemberg · founded 2006$137.4Mraised▾
Manufacturer of portable power supplies providing sustainable and reliable energy. These power supplies offer an alternative to traditional generators. The product line includes a fleet management application. The company focuses on reducing emissions and lowering operational costs.
- Jan 2024Series C$95M
- Feb 2022Series B$33M
- Feb 2020Series A$9.4M
#4
Acquired · Tubingen, Baden Wurttemberg · founded 2000 · 648 employees$975.3Mraised▾
Developer of mRNA-based therapeutics against cancer and infectious diseases. It has developed RNAntibody to enable the expression of functional antibodies and antibody-like proteins from mRNA. The lead product includes CV9104, an investigational therapeutic vaccine to treat prostate cancer. The vaccine is injected into the skin to stimulate the body's immune system to destroy prostate cancer cells. The company's other product includes CV8102 for cutaneous myeloma and CV9202 used to treat patients with non-small cell lung cancer.
- Sep 2020Grant (prize money)$299M
- Jul 2020Series F$126M
- Jul 2020Series F$171M
- Jul 2020Conventional Debt$84.3M
#5
Deadpooled · Walldorf, Baden Wurttemberg · founded 2012 · 5 employees$37.8Mraised▾
FuelSave is a provider of solutions to improve the efficiency of fuel usage. Solutions are offered for vehicles, marine thermoelectric, and purifier applications to reduce fuel consumption by engines. These solutions include FS vehicle, marine, power, heat, ignition, and engineplus, each with sub solutions and components aimed at improved fuel consumption in the respective applications.
- Jun 2022Series C$33.8M
- Sep 2021Series A$4M
- Nov 2020Grant (prize money)$3.7K
- Nov 2020Grant (prize money)$67K
#6
Series B · Freiburg im Breisgau, Baden Wurttemberg · founded 2016 · 74 employees$27.7Mraised▾
SpinDiag, a spin-off of Hahn-Schickard, develops a point-of-care system. The automated system helps in the screening drug-resistant pathogens. The system, LabDisk, is based on a patented centrifugal-microfluidic technology which provides PCR results directly from patient swab samples.
- Oct 2022Conventional Debt$14.6M
- May 2020Series B$17.8M
- Apr 2020Series B$6.5M
- Nov 2018Series A$3.4M
#7
Acquired · Holzgerlingen, Baden Wurttemberg · founded 2007 · 55 employees$127.1Mraised▾
Curetis provides a molecular diagnostics device to detect infectious diseases. The company focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. The company develops the Unyvero A50 System for the detection of bacterial infections using PCR technology in hospitalized patients. Using a variety of cartridges, diseases such as pneumonia or implant and tissue infections can also be diagnosed within 4–5 hours.
- Sep 2020Grant (prize money)$409.7K
- Jul 2020Conventional Debt$5.7M
- May 2019Series C$1.7M
- May 2019Conventional Debt$5.6M
#8
Acquired · Bruchsal, Baden Wurttemberg · founded 2008 · 116 employees$80Mraised▾
Cynora develops blue organic light-emitting diode (OLED) emitters. The company's focus is on the TADF (thermally activated delayed fluorescence) technology, which it claims to help achieve efficient blue emission and allows the development of OLEDs displays with significantly reduced power consumption while simultaneously improving display resolution.
- May 2019Series C$25M
- Jan 2019Grant (prize money)$31.6K
- Sep 2017Series B$30M
- Jan 2015Grant (prize money)$544K
#9
Funding Raised · Stuttgart, Baden Wurttemberg · founded 1988$20.1Mraised▾
ZSW is a provider of renewable energy technology solutions. Their technology CIGS is a thin-film based solar module. It provides technology solutions for photovoltaic, regenerative fuel, batteries, fuel cell, system analysis, grid integration, and others. It also provides consulting services for renewable energy storage.
- Jan 2021Grant (prize money)$729.7K
- Aug 2020Grant (prize money)$12.5M
- Jan 2020Grant (prize money)$673.1K
- Jul 2019Grant (prize money)$152.3K
#10
Funding Raised · Freiburg im Breisgau, Baden Wurttemberg · founded 2019 · 25 employees$6.2Mraised▾
Developer of dispensing technology for industrial mass production and process development. The company provides solutions from design and process development to automation and paste development. It leverages a network of paste manufacturers and automation experts. Products include slot die kits, multi-nozzle units, and single-nozzle units. The company also offers coating units, parallel dispensing units, and fluid dispensers.
- Jun 2022Grant (prize money)$6.2M
#11
Series B · Tubingen, Baden Wurttemberg · founded 2015 · 13 employees$13.7Mraised▾
Re-purposing MEK inhibitors to treat viral infections including COVID-19 and influenza. The company therapeutics focuses on repurposing existing so-called MEK-inhibitors, originally used in oncology, which is already marketed or has undergone clinical investigations, to treat severe viral infections that lead to seasonal influenza and pandemic COVID-19. The working hypothesis is that virus replication is dependent on a specific cellular pathway, which can be effectively blocked by MEK-inhibitors. Three patent families that also repurpose MEK inhibitors for antiviral use were transferred during the foundation process.
- Oct 2020Venture Debt$28.2M
- Aug 2020Series B$10.2M
- Jan 2019Series A—
- Oct 2017Seed$3.5M
#12
Series B · Weil am Rhein, Baden Wurttemberg · founded 2013 · 10 employees$44.4Mraised▾
Developer of antibiotics for the treatment of multi-drug-resistant bacterial infections. The company has developed two product candidates cefepime and enmetazobactamto treat Gram-negative multi-drug-resistant infections such as complicated urinary tract infections.
- Jun 2016Series B$24.7M
- Apr 2013Series A$19.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Sustainability Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.